Dr Reddys Laboratories Ltd (RDY) income statement
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Score 7/30
$14.98+0.19 (+1.28%)
Close on Nov 18, 2026Market cap $12.50BP/E 27.5Yield 0.57%
Dr Reddys Laboratories Ltd income statement
Ratios
Latest available, balances at Mar 31, 2026
Profitability, FY2026
- Gross margin
- 52.8%
- Operating margin
- 15.0%
- Net margin
- 12.8%
- Return on equity, FY2026
- 12.1%
Financial strength
- Current ratio
- 1.80
- Debt to equity
- 0.21
- Debt to assets
- 13.3%
- Cash to current liabilities
- 9.2%
Valuation
- P/E ratio
- 27.5
- Price to sales
- 3.51
- Price to book
- 3.12
- Dividend yield
- 0.57%
See a number that looks wrong?